Cancer Research Horizons is the London-based venture and translational investment arm of Cancer Research UK, backing early-stage cancer-focused innovations through its Seed Fund. It invests in seed and early-stage companies across therapeutics, diagnostics, medical devices, biotechnology, life sciences, healthtech, data and AI, and pharmaceuticals. The firm targets patient-impact-driven oncology innovation and has supported investment activity in the United Kingdom, Netherlands and worldwide.